Public signalCompany raiseAuto-indexed · Unverified

Kytopen Corp. raised $5.7M

Kytopen Corp.· CAMBRIDGE, US· Biotechnology· Filed Feb 15, 2024

Kytopen Corp. reported raising capital. Based in CAMBRIDGE, MASSACHUSETTS, US. First sale reported 2024-01-31. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$5.7M
Confidence90%
Raised
$5.7M
Investors
22
Jurisdiction
DELAWARE

On the record

Location
CAMBRIDGE, US
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$5.7M
Target amount
$8.0M
Filing date
Feb 15, 2024
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Industry group
Biotechnology
Number of investors
22
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$8.0M
Amendment
No

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 5,691,637 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Feb 15, 2024. Details beyond the filing have not been verified.

Tags

USCompanyBiotechnology$1M – $10MCompany Raise

Are you associated with Kytopen Corp.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record